In the present study, chitosan-fibrin nanocomposites (CFNs) were prepared using a novel method and analysed for their physico-chemical properties. TEM and SEM studies revealed their size in the range of 24-28 nm with zeta potential value of + 16 mV. Anti-bacterial activity of CFN was investigated against Escherichia coli and Staphylococcus aureus. For drug delivery applications, 71% of methotrexate (MTX) was entrapped in CFNs that displayed sustained release for up to 96 h. Anti-cancer activity of MTX-CFN was evaluated on HeLa and MCF 7 cells, which showed dose-dependent toxicity on both the cell lines. Further, the role of CFN in wound healing was studied by creating open excision wounds on albino rats. Topical application of CFN, once in two days, for up to 10 days resulted in complete healing of wounds on day 14 whereas it took 22 days in control. Histological and biochemical analyses proved increased synthesis of collagen with active migration of fibroblasts and epithelial cells in CFN treated wounds. From our study, it is proposed that CFN may be used as a suitable candidate for drug delivery and wound healing applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1166/jbn.2015.1948 | DOI Listing |
Fracture-related infection (FRI) is a serious complication that occurs primarily in surgically treated fractures. FRIs occur when bacteria enter the site of bony injury and alter the healing inflammatory response within the bone. This can prevent bone regeneration and can lead to long-lasting complications such as chronic infection, pain, nonunion, and amputation.
View Article and Find Full Text PDFEur J Breast Health
January 2025
Department of General Surgery, Gülhane Training and Research Hospital, University of Health Sciences Turkey, Ankara, Turkey.
Pyoderma gangrenosum (PG) is a rare, chronic, neutrophilic dermatosis characterized by painful ulcers that are often misdiagnosed as wound infections. We report two cases of postsurgical PG following breast surgery: A 46-year-old woman with a non-healing ulcer after a breast biopsy and a 37-year-old woman with wound dehiscence after bilateral reduction mammoplasty. Both cases were initially managed with repeated debridements, antibiotics, and wound care without improvement.
View Article and Find Full Text PDFUrogynecology (Phila)
December 2024
University of Pittsburgh, Pittsburgh, PA.
Importance: Wound complications after obstetric anal sphincter injury (OASI) can amplify morbidity and affect quality of life.
Objective: The objective of this study was to evaluate for characteristics associated with wound complications after OASI.
Study Design: This was a retrospective cohort study of patients with an OASI who were evaluated in a postpartum pelvic floor healing clinic between November 1, 2020, and May 16, 2023.
J Adv Nurs
January 2025
School of Nursing, Beijing University of Chinese Medicine, Beijing, China.
Aims: To develop the core outcome set and identify unique outcomes for the three stages and five types of nursing interventions, respectively, in lactational mastitis.
Design: A mixed methods study.
Methods: A systematic literature search, four semi-structured interviews for key stakeholders, two rounds of Delphi surveys and two online consensus meetings were conducted.
J Cancer
January 2025
Department of Oral and Maxillofacial Surgery, School of Stomatology, Hebei Medical University, Hebei Technology Innovation Center of Oral Health, Key Laboratory of Stomatology and Clinical Research Centre for Oral Diseases, Hebei Province, Shijiazhuang, 050017, China.
HOXD13, a member of the homeobox gene family, plays a critical role in developmental processes and has been implicated in various malignancies, including pancreatic cancer and glioma. However, its role in oral squamous cell carcinoma (OSCC) remains poorly understood. This study aimed to elucidate the potential of HOXD13 as a diagnostic biomarker and therapeutic target for OSCC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!